Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600129149) titled 'Multimodal MRI-Based Quantification of Intratumoral Heterogeneity for Predicting Molecular Subtypes and Prognosis in Breast Cancer' on July 31.

Study Type: Observational study

Study Design: Cohort study

Primary Sponsor: Zhejiang Provincial Hospital of TCM

Condition: Breast cancer

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-08-01

Target Sample Size: Breast cancer group:500;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=332756

Published by HT Digital Content Services with permission from Health Daily Digest....